Metal Nanozymes Modulation of Reactive Oxygen Species As Promising Strategies for Cancer Therapy

Jin-Wei Bu,Zhi-Gang Wang,Hao-Yang Liu,Shu-Lin Liu
DOI: https://doi.org/10.1016/j.ijpharm.2024.124453
IF: 6.51
2024-01-01
International Journal of Pharmaceutics
Abstract:Nanozymes, nanostructured materials emulating natural enzyme activities, exhibit potential in catalyzing reactive oxygen species (ROS) production for cancer treatment. By facilitating oxidative reactions, elevating ROS levels, and influencing the tumor microenvironment (TME), nanozymes foster the eradication of cancer cells. Noteworthy are their superior stability, ease of preservation, and cost-effectiveness compared to natural enzymes, rendering them invaluable for medical applications. This comprehensive review intricately explores the interplay between ROS and tumor therapy, with a focused examination of metal-based nanozyme strategies mitigating tumor hypoxia. It provides nuanced insights into diverse catalytic processes, mechanisms, and surface modifications of various metal nanozymes, shedding light on their role in intra-tumoral ROS generation and applications in antioxidant therapy. The review concludes by delineating specific potential prospects and challenges associated with the burgeoning use of metal nanozymes in future tumor therapies.
What problem does this paper attempt to address?